Treace Medical Concepts (TMCI) CFO has 4,659 shares withheld for taxes

Rhea-AI Filing Summary

Treace Medical Concepts, Inc. Chief Financial Officer Mark Hair reported routine share dispositions tied to tax withholding on equity compensation. On March 8 and March 10, 2026, a total of 4,659 shares of common stock were withheld to satisfy tax liabilities, rather than sold on the open market.

After these transactions, Hair directly holds 863,549 shares of common stock, which includes 723,147 restricted stock units as of March 10, 2026. These entries reflect compensation-related mechanics, not discretionary buying or selling.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Hair Mark

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	3,695	$0.00	--
Tax Withholding	Common Stock	964	$0.00	--

Holdings After Transaction: Common Stock — 863,549 shares (Direct)

Footnotes (1)

1. Includes 723,147 restricted stock units. Includes 711,691 restricted stock units.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hair Mark

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FL 32081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/08/2026		F		964	D	$0	867,244(1)	D
Common Stock	03/10/2026		F		3,695	D	$0	863,549(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 723,147 restricted stock units.

2. Includes 711,691 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Mark Hair	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TMCI CFO Mark Hair report in this Form 4 filing?

Mark Hair reported tax-related share dispositions. The Treace Medical Concepts CFO had 4,659 common shares withheld on March 8 and March 10, 2026 to satisfy tax obligations on equity compensation, rather than conducting open-market sales.

How many TMCI shares were withheld for taxes for the CFO?

A total of 4,659 shares were withheld. Two code F transactions on March 8 and March 10, 2026 show 964 and 3,695 common shares delivered to cover tax liabilities arising from equity awards.

How many Treace Medical Concepts (TMCI) shares does the CFO hold after these transactions?

Mark Hair holds 863,549 shares after the transactions. As of March 10, 2026, his direct holdings in Treace Medical Concepts common stock total 863,549 shares, including a substantial portion in restricted stock units.

How many restricted stock units are included in the TMCI CFO’s holdings?

The CFO’s latest reported holdings include 723,147 restricted stock units. A footnote explains that, as of March 10, 2026, this number of RSUs is part of his total 863,549-share direct position in Treace Medical Concepts.

Were the TMCI CFO’s reported Form 4 transactions open-market sales or routine tax withholding?

The transactions are routine tax-withholding dispositions. Both entries are coded F, described as payment of tax liability by delivering securities, indicating shares were withheld for taxes rather than sold in discretionary market transactions.